Nektar Therapeutics (NKTR) Reports Q4 Loss of $0.46

February 28, 2013 4:58 PM

Nektar Therapeutics (NASDAQ: NKTR) reported Q4 EPS of ($0.46) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found